12 filings · most recent first
TEVA 8-K Filings
Teva Pharmaceutical Announces 2025 Financial Results
Teva Pharmaceuticals Presents Forwardlooking Financial Guidance At Jp Morgan
Teva Pharmaceutical Extends Revolving Credit Agreement Maturity Date
Teva Pharmaceuticals Annual Meeting Results
Teva Pharmaceutical Issues 22 Billion In Senior Notes
Teva Announces Successful Upsizing And Pricing Of 23 Billion Senior Notes
Teva Pharmaceutical Appoints Chen Lichtenstein To Board Of Directors
Teva Pharmaceutical Announces Third Quarter 2025 Financial Results
Teva Pharmaceutical Announces Q2 2025 Financial Results
Teva Pharmaceutical Reports 2025 Q1 Financial Results
Teva Pharmaceutical Reports 2024 Financial Results
Teva Pharmaceutical Reports Third Quarter 2024 Financial Results